CHICAGO, Ill., July 30, 2025 /PRNewswire/ — Singlepoint Healthcare (Singlepoint), today announced its official launch as a new healthcare organization focused on providing integrated, patient-centered care for individuals living with complex inflammatory diseases, combining best-in-class infusion services with holistic disease management. Singlepoint is building a multi-specialty network that brings neurology, rheumatology and immunology together with key ancillary services… Read more »
Herspiegel, a portfolio company of DFW Capital Partners, and a leader in pharmaceutical commercialization consulting services, today announced the acquisition of U.K.-based Decisive Consulting, following the company’s acquisition of leading U.K.-based HEOR and market access firm FIECON in April 2025. This strategic expansion unites Decisive’s global market access focused “Rebel Thinking” with Herspiegel’s world-class commercialization… Read more »
DFW Capital Partners (“DFW”) announced today that it has hired Peter Conzola as Vice President, Business Development. In this role, Peter will oversee deal origination and sourcing activities at the firm. Prior to joining DFW, Peter served as Vice President, Head of Business Development at SFW Capital Partners where he led the firm’s sourcing activities.… Read more »
[Meridian, Idaho] – May 1, 2025 – The newly branded Sorren, a Top 50 accounting firm, was established by a collection of like-minded firms from across the country with the desire to create one firm and a shared purpose. The collection of firms, long connected through the BDO Alliance and industry relationships, have now formalized… Read more »
Tegoprazan proves to be faster acting and more effective than a proton pump inhibitor (PPI) in the healing of erosive esophagitis (EE). Met all primary and secondary endpoints in healing phase of EE. Demonstrated superiority over lansoprazole, a PPI, in healing at weeks 2 and 8 in all grades of EE. Tegoprazan met all primary… Read more »
SL1009 targets a 2025 FDA decision for Pyruvate Dehydrogenase Complex Deficiency (PDCD), while SL1002 advances toward Phase III trials for osteoarthritis knee pain and spasticity ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, April 17, 2025 /PRNewswire/ — Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced multiple updates on its rapidly advancing clinical development portfolio. SL1009, Sodium Dichloroacetate (DCA)DCA is an… Read more »
April 15, 2025 – Voiant, a leader in clinical trial imaging solutions, today is announcing the acquisition of Voxeleron, a pioneering company in AI-driven ophthalmic image analysis. This strategic acquisition marks a significant advancement in Voiant’s mission to accelerate the development of innovative treatments for eye diseases. Voiant’s extensive ophthalmic clinical trial expertise coupled with… Read more »
YARDLEY, Pa. and LONDON, April 7, 2025 /PRNewswire/ — Herspiegel, a world leader in pharmaceutical and biotech commercialization services, continues its strategic expansion by joining forces with FIECON, Europe’s leading health economics and market access consultancy firm. This strategic integration expands Herspiegel’s proven market access capabilities and enhances Herspiegel’s global footprint. The integrated global access services will support patient access… Read more »
MORRISVILLE, N.C.- AQUALIS, the nation’s leading provider of sustainable water management, engineering and compliance services for critical infrastructure, announced today it has acquired the assets of Stormwater Compliance Solutions, LLC (SCS). Headquartered in Chester, N.J. with a second office in the Greater Denver area, Stormwater Compliance Solutions has been performing stormwater inspections, maintenance and compliance… Read more »
CLEVELAND, OH. – March 12, 2025 PrivateEquityCXO and Falcon Partners have announced 2025’s Top 50 Private Equity Firms who best enable their portfolio company executives to drive maximum returns. Winners are determined through data collected from thousands of sponsor-backed executives highlighting their experiences and rating funds using PE-CXO’s Nine Dimensions of Governance Fit®, a… Read more »
